These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 27662365

  • 1. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
    Lettini G, Sisinni L, Condelli V, Matassa DS, Simeon V, Maddalena F, Gemei M, Lopes E, Vita G, Del Vecchio L, Esposito F, Landriscina M.
    Cell Death Differ; 2016 Nov 01; 23(11):1792-1803. PubMed ID: 27662365
    [Abstract] [Full Text] [Related]

  • 2. TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation.
    Lettini G, Condelli V, Pietrafesa M, Crispo F, Zoppoli P, Maddalena F, Laurenzana I, Sgambato A, Esposito F, Landriscina M.
    Int J Mol Sci; 2020 Oct 13; 21(20):. PubMed ID: 33065966
    [Abstract] [Full Text] [Related]

  • 3. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F, Shang S, Yang YW, Zhang HZ, Xu TL, Yu JJ, Zhou DD, Cui B, Li K, Lv XX, Zhang XW, Liu SS, Yu JM, Wang F, Zhang C, Huang B, Hu ZW.
    Gastroenterology; 2019 Feb 13; 156(3):708-721.e15. PubMed ID: 30365932
    [Abstract] [Full Text] [Related]

  • 4. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
    Liu D, Du L, Chen D, Ye Z, Duan H, Tu T, Feng J, Yang Y, Chen Q, Yan X.
    Oncotarget; 2016 Jun 28; 7(26):40704-40718. PubMed ID: 27302922
    [Abstract] [Full Text] [Related]

  • 5. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
    Venugopal A, Subramaniam D, Balmaceda J, Roy B, Dixon DA, Umar S, Weir SJ, Anant S.
    Mol Carcinog; 2016 Nov 28; 55(11):1503-1516. PubMed ID: 26331352
    [Abstract] [Full Text] [Related]

  • 6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD, Sun GB, Jiao P, Chen C, Liu QF, Huang XL, Zhang R, Cai WY, Li SN, Wu JF, Liu YJ, Wu RS, Xie YY, Chan EC, Liou YC, Li BA.
    Gastroenterology; 2016 Mar 28; 150(3):659-671.e16. PubMed ID: 26619963
    [Abstract] [Full Text] [Related]

  • 7. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
    Condelli V, Maddalena F, Sisinni L, Lettini G, Matassa DS, Piscazzi A, Palladino G, Amoroso MR, Esposito F, Landriscina M.
    Oncotarget; 2015 Sep 08; 6(26):22298-309. PubMed ID: 26084290
    [Abstract] [Full Text] [Related]

  • 8. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
    Liu X, Su K, Sun X, Jiang Y, Wang L, Hu C, Zhang C, Lu M, Du X, Xing B.
    J Exp Clin Cancer Res; 2021 Apr 15; 40(1):132. PubMed ID: 33858476
    [Abstract] [Full Text] [Related]

  • 9. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC, Xu J, Bian X, Wu JL, Kang W, Qian Y, Li W, Chen H, Gou H, Liu D, Yat Luk ST, Zhou Q, Ji F, Chan LS, Shirasawa S, Sung JJ, Yu J.
    Gastroenterology; 2020 Dec 15; 159(6):2163-2180.e6. PubMed ID: 32814111
    [Abstract] [Full Text] [Related]

  • 10. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X, Yang X, Zhao J, Lu J, Guan S, Lu J, Kovacevic Z, Liu W, Mi L, Jin R, Sun J, Yue F, Ma J, Lu A, Richardson DR, Wang L, Zheng M.
    Oncotarget; 2015 Oct 20; 6(32):33893-911. PubMed ID: 26418878
    [Abstract] [Full Text] [Related]

  • 11. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q, Chen J, Di Z, Yuan W, Zhou Z, Liu Z, Han S, Liu Y, Ying G, Shu X, Di M.
    J Exp Clin Cancer Res; 2020 Nov 05; 39(1):232. PubMed ID: 33153498
    [Abstract] [Full Text] [Related]

  • 12. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
    Jung YS, Jun S, Lee SH, Sharma A, Park JI.
    Oncotarget; 2015 Nov 10; 6(35):37257-68. PubMed ID: 26484565
    [Abstract] [Full Text] [Related]

  • 13. AGR2 is a target of canonical Wnt/β-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells.
    Dahal Lamichane B, Jung SY, Yun J, Kang S, Kim DY, Lamichane S, Kim YJ, Park JH, Jang WB, Ji ST, Dehua L, Ha JS, Kim YH, Kwon SM.
    Biochem Biophys Res Commun; 2019 Aug 06; 515(4):600-606. PubMed ID: 31178140
    [Abstract] [Full Text] [Related]

  • 14. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M, Miao F, Huang R, Liu W, Zhao Y, Jiao T, Lu Y, Wu F, Wang X, Wang H, Zhao H, Ju H, Miao S, Wang L, Song W.
    J Exp Clin Cancer Res; 2018 Feb 09; 37(1):22. PubMed ID: 29426364
    [Abstract] [Full Text] [Related]

  • 15. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC, Liu YS, Tseng KC, Tan BC, Chen SJ, Chen HC.
    Cell Signal; 2014 Nov 09; 26(11):2333-42. PubMed ID: 25025569
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T, Hu K, Zhao Z, Chen G, Ou X, Zhang H, Zhang X, Wei X, Wang D, Cui M, Liu C.
    Oncotarget; 2015 Dec 08; 6(39):41638-49. PubMed ID: 26497855
    [Abstract] [Full Text] [Related]

  • 17. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
    Wang L, Deng K, Gong L, Zhou L, Sayed S, Li H, Sun Q, Su Z, Wang Z, Liu S, Zhu H, Song J, Lu D.
    Pharmacol Res; 2020 Sep 08; 159():104955. PubMed ID: 32485279
    [Abstract] [Full Text] [Related]

  • 18. The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells.
    Dong HJ, Jang GB, Lee HY, Park SR, Kim JY, Nam JS, Hong IS.
    Sci Rep; 2016 Mar 11; 6():22966. PubMed ID: 26965643
    [Abstract] [Full Text] [Related]

  • 19. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q, Yao G, Zhang M, Guo G, Hu Y, Jiang J, Cheng L, Shi J, Li H, Zhang Y, Liu H.
    Carcinogenesis; 2015 Mar 11; 36(3):318-26. PubMed ID: 25600769
    [Abstract] [Full Text] [Related]

  • 20. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
    Chen JF, Luo X, Xiang LS, Li HT, Zha L, Li N, He JM, Xie GF, Xie X, Liang HJ.
    Oncotarget; 2016 Jul 05; 7(27):41540-41558. PubMed ID: 27172794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.